State Board of Administration of Florida Retirement System boosted its holdings in shares of Penumbra, Inc. (NYSE:PEN) by 5.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,975 shares of the company’s stock after buying an additional 730 shares during the quarter. State Board of Administration of Florida Retirement System’s holdings in Penumbra were worth $1,262,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the business. Suntrust Banks Inc. raised its position in Penumbra by 2.6% during the 2nd quarter. Suntrust Banks Inc. now owns 4,023 shares of the company’s stock worth $353,000 after buying an additional 101 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank raised its position in Penumbra by 10.9% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,159 shares of the company’s stock worth $102,000 after buying an additional 114 shares during the last quarter. Principal Financial Group Inc. raised its position in Penumbra by 0.9% during the 1st quarter. Principal Financial Group Inc. now owns 13,031 shares of the company’s stock worth $1,087,000 after buying an additional 121 shares during the last quarter. Ameritas Investment Partners Inc. raised its position in Penumbra by 10.8% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,573 shares of the company’s stock worth $226,000 after buying an additional 250 shares during the last quarter. Finally, Stifel Financial Corp raised its position in Penumbra by 2.1% during the 2nd quarter. Stifel Financial Corp now owns 16,226 shares of the company’s stock worth $1,421,000 after buying an additional 340 shares during the last quarter. 71.40% of the stock is owned by institutional investors.

Shares of Penumbra, Inc. (NYSE PEN) opened at $104.55 on Friday. Penumbra, Inc. has a one year low of $57.85 and a one year high of $116.35.

Penumbra (NYSE:PEN) last issued its quarterly earnings data on Tuesday, November 7th. The company reported $0.01 EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.07. The business had revenue of $83.90 million for the quarter, compared to analysts’ expectations of $79.17 million. Penumbra had a negative net margin of 2.19% and a negative return on equity of 1.95%. The business’s revenue was up 24.9% on a year-over-year basis. During the same quarter last year, the company earned ($0.04) EPS. sell-side analysts predict that Penumbra, Inc. will post -0.15 earnings per share for the current year.

PEN has been the subject of a number of recent research reports. Canaccord Genuity raised their price target on shares of Penumbra from $100.00 to $113.00 and gave the stock a “buy” rating in a research report on Wednesday, November 8th. BidaskClub raised shares of Penumbra from a “hold” rating to a “buy” rating in a research report on Saturday, August 12th. BMO Capital Markets reissued a “buy” rating and set a $96.00 price target on shares of Penumbra in a research report on Friday, October 13th. Finally, Zacks Investment Research raised shares of Penumbra from a “sell” rating to a “hold” rating in a research note on Wednesday, October 11th.

ILLEGAL ACTIVITY NOTICE: This piece was first published by Daily Political and is the property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The correct version of this piece can be read at https://www.dailypolitical.com/2017/11/18/state-board-of-administration-of-florida-retirement-system-acquires-730-shares-of-penumbra-inc-pen.html.

In other news, Director Thomas Wilder sold 345 shares of the firm’s stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $90.20, for a total transaction of $31,119.00. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Adam Elsesser sold 24,444 shares of the firm’s stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $105.83, for a total transaction of $2,586,908.52. Following the sale, the chief executive officer now directly owns 1,231,338 shares in the company, valued at approximately $130,312,500.54. The disclosure for this sale can be found here. Insiders have sold a total of 88,694 shares of company stock worth $8,773,076 in the last ninety days. Corporate insiders own 13.50% of the company’s stock.

Penumbra Profile

Penumbra, Inc is a healthcare company focused on interventional therapies. The Company designs, develops, manufactures and markets medical devices. It has a portfolio of products that addresses medical conditions and clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures.

Institutional Ownership by Quarter for Penumbra (NYSE:PEN)

Receive News & Ratings for Penumbra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Penumbra Inc. and related companies with MarketBeat.com's FREE daily email newsletter.